NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 08/12/2026 16:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization978.5 mln
Float27.06 mln
Earnings Date03/04/2027
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-3.04
Reliable
Relative Strength
92
/ 100
Top performer
Debt / Equity
0.08
Debt-free
ROE
-4.18
Negative
Dividend Yield
0.00%
No dividend
Business Description
Castle Biosciences is a medical testing company that uses gene analysis to help doctors make better treatment decisions for patients with skin cancers, esophageal conditions, and related diseases. Its portfolio of proprietary tests helps predict how a patient's condition may progress, identify difficult-to-diagnose cases, and guide the selection of appropriate therapies. Founded in 2007 and based in Friendswood, Texas, the company primarily serves dermatology and gastroenterology specialists across the United States.
